Welcome to the Medicines Evaluation Board (MEB) website for the Dutch EU Presidency! This website has been set up for the organisation of all the meetings hosted by the MEB.

The MEB assesses and monitors the efficacy, risks and quality of human and veterinary medicinal products, and the safety of novel foods for human consumption. The MEB is the Dutch National Competent Authority (NCA) and is member of the Heads of Medicines Agencies (HMA). The HMA is a network of all heads of the NCA whose organisations are responsible for the regulation of medicinal products for human and veterinary use in the European Economic Area. The HMA co-operates with the European Medicines Agency (EMA) and the European Commission in the operation of the European medicines regulatory network and it is a unique model for cooperation and work sharing on statutory as well as voluntary regulatory activities. The NCAs are responsible for the authorisation of decentralised national pharmaceuticals,

The MEB will host a range of meetings during the Dutch EU Presidency. A total of eighteen meetings will be organised, with the two HMA meetings with all the heads of National Competent Authorities, as the two major events. Besides the two HMA meetings different working groups of the HMA will have their meetings in the Netherlands, as well as the committees that usually meet at the EMA.

eu2016cbgmeb